Grupo 702
Fisiopatología e Historia Natural de las Enfermedades Hepáticas y Gastroenterológicas
Publicaciones (598)
-
Iruzubieta, P; Mayo, R; Mincholé, I; Martínez-Arranz, I; Arias-Loste, MT; Ibañez-Samaniego, L; Ampuero, J; Abad, J; Martín-Mateos, R; Fernández-Laso, AB; Albillos, A; Banares, R; Calleja, JL; Romero-Gómez, M; Aller, R; Crespo, J.
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
United European Gastroenterology Journal. 2024; 12(7): 919-929 Nº de citas: 7 [doi:10.1002/ueg2.12589]
-
Romero-Gutiérrez M; Pascual S; Márquez L; Gómez-Rubio M; Miquel M; Alarcón C; Ferrer T; Aracil C; Horta D; Latorre R; González Santiago J; Bernal V; Fernández C; Piqueras B; Gutiérrez ML; Martín A; Morillas J; Morales D; Blanco S; Rendón P; Chico I; Testillano M; Delgado C; Matilla A; Gómez Rodríguez R.
Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series.
Gastroenterologia y Hepatologia. 2024; 47(7): 683-690 [doi:10.1016/j.gastrohep.2023.08.008]
-
Alvarado-Tapias, E; Marti-Aguado, D; Gomez-Medina, C; Ferrero-Gregori, A; Szafranska, J; Brujats, A; Osuna-Gomez, R; Guinart-Cuadra, A; Alfaro-Cervello, C; Pose, E; Ventura-Cots, M; Clemente, A; Fernandez-Carrillo, C; Contreras, C; Cabezas, J; Lopez-Pelayo, H; Arab, J; Argemi, J; Bataller, R.
Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality
Hepatology Communications. 2024; 8(8): [doi:10.1097/HC9.0000000000000490]
-
Romero-Cristóbal, M; Díaz-Fontenla, F; Fernández-Yunquera, A; Caballero-Marcos, A; Conthe, A; Velasco, E; Pérez-Peña, J; López-Baena, JA; Rincón, D; Bañares, R; Salcedo, M.
Demographic Trends in Liver Transplant Survivors After 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy
Transplantation Direct. 2024; 10(8): [doi:10.1097/TXD.0000000000001684]
-
Rodríguez-Perálvarez, ML; de la Rosa, G; Gómez-Orellana, AM; Aguilera, MV; Vicente, TP; Pereira, S; Ortiz, ML; Pagano, G; Suarez, F; Grande, RG; Cachero, A; Tomé, S; Barreales, M; Mateos, RM; Pascual, S; Romero, M; Bilbao, I; Martín, CA; Otón, E; Diéguez, LG; Espinosa, MD; Milla, AA; Fernández, GB; Lorente, S; Lavín, AC; García, AR; Cano, CS; Cepeda-Franco, C; Pons, JA; Colmenero, J; Guijo-Rubio, D; Otero, A; Navarrete, AA; Moreno, SR; Soler, MR; Martínez, CH; Gastaca, M.
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study
EClinicalMedicine. 2024; 74: Nº de citas: 17 [doi:10.1016/j.eclinm.2024.102737]
-
Semmler, G; López, SA; Pons, M; Lens, S; Dajti, E; Griemsmann, M; Zanetto, A; Burghart, L; Hametner-Schreil, S; Hartl, L; Manzano, M; Rodriguez-Tajes, S; Zanaga, P; Schwarz, M; Gutierrez, ML; Jachs, M; Pocurull, A; Polo, B; Ecker, D; Mateos, B; Izquierdo, S; Real, Y; Balcar, L; Carbonell-Asins, JA; Gschwantler, M; Russo, FP; Azzaroli, F; Maasoumy, B; Reiberger, T; Forns, X; Genesca, J; Bañares, R; Mandorfer, M; Agostini, SM; Battistella, S; Casanova-Cabral, M; Bauer, DJM; Chromy, D; Cornberg, M; Deterding, K; Fernandez, I; Fernandez-Rodriguez, C; Gea, F; Krawanja, J; Mauz, JB; Neumayer, D; Ahumada, A; Riado, D; Rincón, D; Schwabl, P; Simbrunner, B; Trauner, M; Uson, C; Wedemeyer, H.
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
HEPATOLOGY. 2024; 81(2): 609-624 Nº de citas: 14 [doi:10.1097/HEP.0000000000001005]
-
Semmler, G; López, SA; Pons, M; Lens, S; Dajti, E; Griemsmann, M; Zanetto, A; Burghart, L; Hametner-Schreil, S; Hartl, L; Manzano, M; Rodriguez-Tajes, S; Zanaga, P; Schwarz, M; Gutierrez, ML; Jachs, M; Pocurull, A; Polo, B; Ecker, D; Mateos, B; Izquierdo, S; Real, Y; Ahumada, A; Bauer, DJM; Mauz, JB; Casanova-Cabral, M; Gschwantler, M; Russo, FP; Azzaroli, F; Maasoumy, B; Reiberger, T; Forns, X; Genesca, J; Bañares, R; Mandorfer, M.
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
JOURNAL OF HEPATOLOGY. 2024; 81(1): Nº de citas: 24 [doi:10.1016/j.jhep.2024.03.015]
-
Melero, I; Yau, T; Kang, YK; Kim, TY; Santoro, A; Sangro, B; Kudo, M; Hou, MM; Matilla, A; Tovoli, F; Knox, J; He, AR; El-Rayes, B; Acosta-Rivera, M; Lim, HY; Soleymani, S; Yao, J; Neely, J; Tschaika, M; Hsu, C; El-Khoueiry, AB.
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
ANNALS OF ONCOLOGY. 2024; 35(6): 537-548 Nº de citas: 64 [doi:10.1016/j.annonc.2024.03.005]
-
Martin-Mateos, R; Martínez-Arenas, L; Carvalho-Gomes, A; Aceituno, L; Cadahía, V; Salcedo, M; Arias, A; Lorente, S; Odriozola, A; Zamora, J; Blanes, M; Len, O; Benítez, L; Campos-Varela, I; González-Diéguez, ML; Lázaro, DR; Fortún, J; Cuadrado, A; Carrasco, NM; Rodríguez-Perálvarez, M; Alvarez-Navascues, C; Fábrega, E; Serrano, T; Cuervas-Mons, V; Rodríguez, M; Castells, L; Berenguer, M; Graus, J; Albillos, A.
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors
JOURNAL OF HEPATOLOGY. 2024; 80(6): Nº de citas: 26 [doi:10.1016/j.jhep.2024.02.023]
-
Jorquera, F; Ledesma, F; Ahumada, A; Manzano, ML; Castiella, A; Lorente, S; Miquel, M; Mariño, Z; Castellote, J; Sanz, E; Uriz, J.
Perfil clínico de los pacientes españoles con hepatitis C naïve con cirrosis compensada tratados en el estudio CREST
Gastroenterologia y Hepatologia. 2024; 47(6): 605-611 [doi:10.1016/j.gastrohep.2024.02.003]
-
Riveiro-Barciela, M; Barreira-Díaz, A; Esteban, P; Rota, R; Alvarez-Navascúes, C; Pérez-Medrano, I; Mateos, B; Gómez, E; De-la-Cruz, G; Ferre-Aracil, C; Horta, D; Díaz-González, A; Ampuero, J; Díaz-Fontenla, F; Salcedo, M; Ruiz-Cobo, JC; Londoño, MC.
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry
LIVER INTERNATIONAL. 2024; 44(9): 2303-2314 Nº de citas: 19 [doi:10.1111/liv.15970]
-
Marañón, P; Rey, E; Isaza, SC; Wu, HH; Rada, P; Choya-Foces, C; Martínez-Ruiz, A; Martín, MA; Ramos, S; García-Monzón, C; Cubero, FJ; Valverde, AM; González-Rodríguez, A.
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury
Redox Biology. 2024; 71: Nº de citas: 10 [doi:10.1016/j.redox.2024.103088]
-
Barreira-Díaz, A; Riveiro-Barciela, M; Fernández-Bonilla, EM; Bernal, V; Castiella, A; Casado-Martín, M; Delgado, C; Londoño, MC; Díaz-González, A; Pérez-Medrano, I; Conthe, A; Sala, M; Mateos, B; Gómez-Camarero, J; Antón-Conejero, D; Del Pozo-Calzada, C; Cuenca, F; Villagrasa-Vilella, A; Salcedo, M.
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Annals of Hepatology. 2024; 29(3): Nº de citas: 3 [doi:10.1016/j.aohep.2024.101489]
-
Gómez-Labrador, C; Ricart, E; Iborra, M; Iglesias, E; Martín-Arranz, MD; de Castro, L; De Francisco, R; García-Alonso, FJ; Sanahuja, A; Gargallo-Puyuelo, CJ; Mesonero, F; Casanova, MJ; Mañosa, M; Rivero, M; Calvo, M; Sierra-Ausin, M; González-Muñoza, C; Calvet, X; García-López, S; Guardiola, J; García, LA; Márquez-Mosquera, L; Gutiérrez, A; Zabana, Y; Navarro-Llavat, M; Poyatos, RL; Piqueras, M; Torrealba, L; Bermejo, F; Ponferrada-Díaz, A; Pérez-Calle, JL; Barreiro-de Acosta, M; Tejido, C; Cabriada, JL; Marín-Jiménez, I; Roncero, O; Ber, Y; Fernández-Salazar, L; Aler, BC; Lucendo, AJ; Llaó, J; Bujanda, L; Villafranca, CM; Domènech, E; Chaparro, M; Gisbert, JP.
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Pharmaceutics. 2024; 16(5): Nº de citas: 6 [doi:10.3390/pharmaceutics16050629]
-
Rodríguez-Moranta, F; Argüelles-Arias, F; del Val, JH; Colomino, MI; Martín-Arranz, MD; Viso, LM; Núñez, FM; Gómez, ER; Sánchez-Hernández, JG; Valdés-Delgado, T; Capón, JG; Barreiro-de Acosta, M; Ciria, MM; Abdo, YZ; Casbas, AG.
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Gastroenterologia y Hepatologia. 2024; 47(5): 522-552 Nº de citas: 21 [doi:10.1016/j.gastrohep.2024.01.007]
-
Oblitas, CM; Demelo-Rodríguez, P; López-Rubio, M; Lago-Rodríguez, MO; García-Gámiz, M; Zamora-Trillo, A; Walther, LAAS; García-Martínez, R; Galeano-Valle, F.
Evaluation of soluble P-selectin as a predictive biomarker in acute symptomatic pulmonary embolism: Insights from a prospective observational study
EUROPEAN JOURNAL OF HAEMATOLOGY. 2024; 113(2): 201-207 Nº de citas: 5 [doi:10.1111/ejh.14218]
-
Lamas-Paz, A; Mesquita, M; Garcia-Lacarte, M; Estévez-Vázquez, O; Benedé-Ubieto, R; Gutierrez, AH; Wu, HH; Lasalle, HL; Vaquero, J; Bañares, R; Martínez-Naves, E; Roa, S; Nevzorova, YA; Jorquera, G; Cubero, FJ.
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol
Frontiers in Nutrition. 2024; 11: Nº de citas: 10 [doi:10.3389/fnut.2024.1393014]
-
Ampuero, J; Aller, R; Gallego-Durán, R; Crespo, J; Calleja, JL; García-Monzón, C; Gómez-Camarero, J; Caballería, J; Lo Iacono, O; Ibañez, L; García-Samaniego, J; Albillos, A; Francés, R; Fernández-Rodríguez, C; Maya-Miles, D; Diago, M; Poca, M; Andrade, RJ; Latorre, R; Jorquera, F; Morillas, RM; Escudero, D; Hernández-Guerra, M; Pareja-Megia, MJ; Banales, JM; Aspichueta, P; Benlloch, S; Rosales, JM; Turnes, J; Romero-Gómez, M.
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
JOURNAL OF GASTROENTEROLOGY. 2024; 59(7): 586-597 Nº de citas: 9 [doi:10.1007/s00535-024-02098-8]